Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -677.82%-570.35M | ---- | 138.76%98.71M | ---- | -799.05%-254.67M | ---- | 117.17%36.43M | ---- | 4.63%-212.16M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -89.66%3K | ---- | 38.10%29K |
| Interest expense - adjustment | ---- | 19.26%260.1M | ---- | -6.78%218.1M | ---- | 23.17%233.97M | ---- | -0.57%189.95M | ---- | 29.92%191.03M |
| Investment loss (gain) | ---- | ---- | ---- | ---330.24M | ---- | ---- | ---- | ---250.65M | ---- | ---- |
| Impairment and provisions: | ---- | 450,087.88%296.99M | ---- | 63.33%-66K | ---- | -122.22%-180K | ---- | -209.46%-81K | ---- | -68.10%74K |
| -Impairment of trade receivables (reversal) | ---- | 112.12%8K | ---- | ---66K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | --296.98M | ---- | ---- | ---- | -122.22%-180K | ---- | -209.46%-81K | ---- | -68.10%74K |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -100.25%-13K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---13K |
| Depreciation and amortization: | ---- | ---- | ---- | -49.97%941K | ---- | -11.69%1.88M | ---- | -7.75%2.13M | ---- | 85.61%2.31M |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 95.31%-280K |
| Operating profit before the change of operating capital | ---- | -5.55%-13.26M | ---- | 33.91%-12.56M | ---- | 14.48%-19M | ---- | -16.92%-22.22M | ---- | 38.82%-19M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | 14.91%1.53M | ---- | -59.43%1.33M | ---- | -46.73%3.27M | ---- | 2,811.85%6.14M | ---- | -96.05%211K |
| Accounts payable increase (decrease) | ---- | -50.94%1.17M | ---- | 146.46%2.39M | ---- | -205.55%-5.13M | ---- | 199.43%4.86M | ---- | 62.66%-4.89M |
| prepayments (increase)decrease | ---- | -99.29%4K | ---- | -82.43%566K | ---- | 386.65%3.22M | ---- | 14.91%-1.12M | ---- | -150.73%-1.32M |
| Cash from business operations | ---- | -27.49%-10.56M | ---- | 53.07%-8.28M | ---- | -43.01%-17.64M | ---- | 50.67%-12.34M | ---- | 30.97%-25.01M |
| Special items of business | 497.22%10.45M | ---- | 39.93%-2.63M | ---- | -53.18%-4.38M | ---- | 81.30%-2.86M | ---- | -57.74%-15.29M | ---- |
| Net cash from operations | 497.22%10.45M | -27.49%-10.56M | 39.93%-2.63M | 53.07%-8.28M | -53.18%-4.38M | -43.01%-17.64M | 81.30%-2.86M | 50.67%-12.34M | -57.74%-15.29M | 30.97%-25.01M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1K | ---- | ---- |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --13K |
| Net cash from investment operations | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -107.69%-1K | ---- | -99.97%13K |
| Net cash before financing | 497.22%10.45M | -27.49%-10.56M | 39.93%-2.63M | 53.07%-8.28M | -53.18%-4.38M | -43.00%-17.64M | 81.30%-2.86M | 50.64%-12.34M | -57.74%-15.29M | -281.70%-24.99M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -0.97%11.19M | ---- | -33.06%11.3M | 37.14%4.8M | -15.60%16.88M | -65.00%3.5M | 53.85%20M | --10M | -22.62%13M |
| Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---10.58M | ---- | ---- |
| Issuing shares | --4.08M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---81K | ---- | ---- | 85.90%-11K | 73.33%-8K | 7.14%-78K | -76.47%-30K | 33.86%-84K | 63.83%-17K | -9.48%-127K |
| Net cash from financing operations | --3.96M | 8.42%11.19M | ---- | -30.83%10.32M | 51.89%3.87M | 104.45%14.92M | -71.35%2.55M | -30.98%7.3M | 787.85%8.89M | 211.55%10.57M |
| Effect of rate | -111.76%-36K | 97.65%-7K | -140.48%-17K | -803.03%-298K | -16.00%42K | -125.58%-33K | 127.32%50K | -72.90%129K | -603.85%-183K | -70.27%476K |
| Net Cash | 647.68%14.4M | -68.90%635K | -414.68%-2.63M | 175.10%2.04M | -63.78%-511K | 46.03%-2.72M | 95.12%-312K | 65.06%-5.04M | 41.74%-6.4M | -437.15%-14.42M |
| Begining period cash | 20.42%3.7M | 131.03%3.08M | 131.03%3.08M | -67.40%1.33M | -67.40%1.33M | -54.59%4.08M | -54.59%4.08M | -60.80%8.99M | -60.80%8.99M | 34.46%22.94M |
| Cash at the end | 4,122.20%18.07M | 20.42%3.7M | -50.35%428K | 131.03%3.08M | -77.44%862K | -67.40%1.33M | 58.48%3.82M | -54.59%4.08M | -79.79%2.41M | -60.80%8.99M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unaudited opinion | -- | -- |
| Auditor | -- | -- | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.